Tocqueville Asset Management L.P. Buys Shares of 66,567 Humana Inc. $HUM

Tocqueville Asset Management L.P. bought a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 66,567 shares of the insurance provider’s stock, valued at approximately $26,442,000. Tocqueville Asset Management L.P. owned about 0.06% of Humana as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of HUM. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Humana by 4.1% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after purchasing an additional 9,960 shares during the last quarter. Sustainable Insight Capital Management LLC lifted its holdings in Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after buying an additional 4,740 shares in the last quarter. Swedbank AB lifted its holdings in Humana by 6.2% during the 4th quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock valued at $28,636,000 after buying an additional 6,534 shares in the last quarter. North Dakota State Investment Board purchased a new stake in Humana in the 4th quarter valued at about $1,517,000. Finally, Pzena Investment Management LLC grew its stake in Humana by 1.0% in the 4th quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock worth $1,043,015,000 after acquiring an additional 41,125 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Raymond James Financial lowered shares of Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. Guggenheim boosted their price target on Humana from $269.00 to $471.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Leerink Partners raised Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective on the stock in a research note on Thursday, July 30th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 target price on shares of Humana in a research report on Wednesday, June 3rd. Finally, The Goldman Sachs Group upped their target price on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a report on Thursday, April 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $395.22.

Humana Stock Performance

HUM stock opened at $377.18 on Thursday. The firm has a market cap of $45.29 billion, a price-to-earnings ratio of 35.68, a PEG ratio of 2.18 and a beta of 0.72. The firm has a 50-day simple moving average of $383.16 and a two-hundred day simple moving average of $279.59. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. During the same period last year, the business earned $6.27 EPS. The company’s revenue was up 26.2% compared to the same quarter last year. On average, equities analysts forecast that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.